Rhonda Cooper-DeHoff, Pharm.D., M.S.
Associate Professor, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida
Associate Director, Center for Pharmacogenomics, University of Florida Clinical and Translational Science Institute
Joint Faculty Appointment, Division of Cardiovascular Medicine, College of Medicine, University of Florida
Leader, Hypertension Team
Member, OneFlorida Steering Committee
Rhonda Cooper-DeHoff, Pharm.D., M.S., is an associate professor in the Department of Pharmacotherapy and Translational Research and the Division of Cardiovascular Medicine, College of Medicine at the University of Florida. She is also the associate director for the Center for Pharmacogenomics. Cooper-DeHoff has spent the last 25 years doing research in the areas of hypertension, atherosclerotic heart disease, as well as metabolic syndrome and diabetes and has contributed significantly to the body of published literature in the area of hypertension, pharmacogenomics and pharmacometabolomics. Cooper-DeHoff has responsibility for all aspects of administration and scientific management of the Hypertension Team within the OneFlorida Clinical Research Consortium. She is also a co-PI for the NIH-funded Pharmacgenomics Evaluation of Antihypertensive Responses grant, as well as a previously funded Career Development Award (K23) entitled “Metabolic Effects of Antihypertensive Drugs.” She was also an investigator of the International Verapamil Trandolapril Study (INVEST), which evaluated hypertension treatments in elderly coronary artery disease patients. Additionally, she has collaborated extensively with rural health care settings regarding hypertension management. Cooper-DeHoff has been elected a Fellow of the American College of Clinical Pharmacy, the American Heart Association and the American College of Cardiology, in accordance with her accomplishments in the clinical and scientific arena of cardiovascular disease.